Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 17.26% is 74% above its 4-year average of 9.90%, around the middle of its 4-year range (-16.04%–60.40%).
18.98% above its 12-month average of 14.51%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 4.16%.
NET PROFIT MARGIN
17.26%
NET PROFIT MARGIN AVG TTM
14.51%
NET PROFIT MARGIN AVG 3Y
7.76%
NET PROFIT MARGIN AVG 5Y
N/A
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+18.98%
CURRENT VS 3Y AVG
+122.38%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+87.51%
vs the sector median at left
Solventum Corporation
Market Cap
$15.51B
Net Profit Margin
17.26%
TTM Avg
14.51%
3Y Avg
7.76%
5Y Avg
N/A
Market Cap
$16.27B
Net Profit Margin
17.67%
TTM Avg
18.50%
3Y Avg
17.20%
5Y Avg
16.74%
Market Cap
$14.56B
Net Profit Margin
35.33%
TTM Avg
28.88%
3Y Avg
23.04%
5Y Avg
19.31%
Market Cap
$13.19B
Net Profit Margin
-5.96%
TTM Avg
-1.67%
3Y Avg
5.09%
5Y Avg
7.31%
Market Cap
$18.02B
Net Profit Margin
9.48%
TTM Avg
10.17%
3Y Avg
9.38%
5Y Avg
6.86%
Market Cap
$12.54B
Net Profit Margin
-9.27%
TTM Avg
-7.30%
3Y Avg
-3.29%
5Y Avg
1.14%
Market Cap
$18.90B
Net Profit Margin
-2.79%
TTM Avg
-14.44%
3Y Avg
-3.94%
5Y Avg
-4.74%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Solventum Corporation (SOLV) | $15.51B | 17.26% | 14.51% | 7.76% | N/A |
| Medpace Holdings, Inc. (MEDP)vs › | $16.27B | 17.67% | 18.50% | 17.20% | 16.74% |
| Exelixis, Inc. (EXEL)vs › | $14.56B | 35.33% | 28.88% | 23.04% | 19.31% |
| Revvity, Inc. (RVTY)vs › | $13.61B | 8.16% | 9.60% | 8.02% | 12.66% |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.19B | -5.96% | -1.67% | 5.09% | 7.31% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.02B | 9.48% | 10.17% | 9.38% | 6.86% |
| Baxter International Inc. (BAX)vs › | $12.54B | -9.27% | -7.30% | -3.29% | 1.14% |
| Penumbra, Inc. (PEN)vs › | $12.57B | 10.67% | 6.92% | 5.54% | 3.35% |
| Viatris Inc. (VTRS)vs › | $18.90B | -2.79% | -14.44% | -3.94% | -4.74% |
| Encompass Health Corporation (EHC)vs › | $12.08B | 10.01% | 9.01% | 7.89% | 8.30% |
Operating Margin
25.0%
Net Profit Margin
17.3%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 4.16% |
| 2026-03-31 | 0.65% |
| 2025-12-31 | 3.15% |
| 2025-09-30 | 60.40% |
| 2025-06-30 | 4.16% |
| 2025-03-31 | 6.62% |
| 2024-12-31 | 1.49% |
| 2024-09-30 | 5.86% |
| 2024-06-30 | 4.28% |
| 2024-03-31 | 11.76% |
| 2023-12-31 | 13.36% |
| 2023-09-30 | 22.18% |
| 2023-06-30 | 15.46% |
| 2023-03-31 | 14.57% |
| 2022-12-31 | -16.04% |
| 2022-09-30 | 16.67% |
| 2022-06-30 | 17.03% |
| 2022-03-31 | 17.03% |
